Non-hodgkin Lymphoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Non-hodgkin Lymphoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Jan 03, 2019

---

• Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.  
  Galanina Natalie et al. Cancers 2018 Dec 11(1)
• Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.  
  Wu Fang-Tian et al. Annals of hematology 2018 Oct
• Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?  
  Davies Andrew et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 284-294
• The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.  
  de Mel Sanjay et al. International journal of molecular sciences 2018 Jun 19(7)
• Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.  
  Shu Wenying et al. Journal of clinical pharmacology 2017 Jul 57(7) 886-898
• Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.  
  Dubois Sydney et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2919-28
• Precision Medicine for Diffuse Large B-cell Lymphoma.  
  Lim Megan S et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2829-31
• Non-Hodgkin lymphoma, childhood  
  From NCATS Genetic and Rare Diseases Information Center
• Non-Hodgkin lymphoma, during pregnancy  
  From NCATS Genetic and Rare Diseases Information Center
• The Promise and Challenges of CAR-T Gene Therapy.  
  Kuehn Bridget M et al. JAMA 2017 Nov